Valeant's Bid for Allergan: Winners and Losers

Valeant Pharmaceuticals' bid for Botox maker Allergan looks very rich.

Apr 22, 2014 at 10:15AM
Longview

Similar to yesterday, U.S. stocks opened little changed on Tuesday, with the benchmark S&P 500 and the narrower Dow Jones Industrial Average (DJINDICES:^DJI) up 0.42% and 0.41%, respectively, at 10:15 a.m. EDT. Nevertheless, news that activist investor Bill Ackman has teamed up with Valeant Pharmaceuticals (NYSE:VRX) on a cash-and-stock offer for Botox maker Allergan (NYSE:AGN)ought to spark investors' animal spirits (as well as trepidation in executive suites -- teaming up with a strategic acquirer is a novel variant of the activist investor's approach.) Couple that with reports that Pfizer conducted preliminary discussions with AstraZeneca regarding a $100 billion takeover. The Financial Times reported that the talks, which took place late last year, have since ended, but that didn't stop investors from bidding up AstraZeneca's shares by nearly 9% yesterday.

Images

Valeant said its offer represents a "substantial premium" over Allergan's undisturbed share price of $116.33 on April 10, the day before Ackman's Pershing Square Capital Management crossed the 5% ownership threshold that requires a public disclosure. Pershing Square is now Allergan's largest shareholder, but it's not the only activist investor in the mix: hedge fund ValueAct Capital is Valeant's third-largest shareholder; its president, G. Mason Morfit, sits on the company's board. (Morfit is a busy man, as you may remember he recently joined Microsoft's board.) The market is certainly validating Valeant's interest -- Allergan's shares were trading up nearly 16% to $164.41 at 10:15 a.m. EDT.

When the dust clears, this looks like a terrific offer from the viewpoint of Allergan's shareholders -- no wonder Ackman is supporting the deal. Even before today's pop, Allergan shares were trading at a rich 26 times next 12 months' earnings-per-share estimate.

But Allergan shareholders' good fortune looks like Valeant investors' burden. The economics are more difficult to square for the acquirer, which is why it's curious that ValueAct Capital, a value investor, appears to support the deal. Indeed, another value-oriented investor that owns Valeant shares isn't impressed with the terms of the deal; as Glenn Greenberg, the managing director of Brave Warrior Advisors, told Reuters: "It's almost impossible to turn it into a high return investment if you pay that kind of price." For now, the market disagrees, shares of Valeant are also up 5.1% this morning.

There's still time to boost your 2014 returns with The Motley Fool's top stock
There's a huge difference between a good stock and a stock that can make you rich. The Motley Fool's chief investment officer has selected his No. 1 stock for 2014, and it's one of those stocks that could make you rich. You can find out which stock it is in the special free report "The Motley Fool's Top Stock for 2014." Just click here to access the report and find out the name of this under-the-radar company.

Alex Dumortier, CFA has no position in any stocks mentioned. The Motley Fool recommends Valeant Pharmaceuticals. The Motley Fool owns shares of Valeant Pharmaceuticals. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

1 Key Step to Get Rich

Our mission at The Motley Fool is to help the world invest better. Whether that’s helping people overcome their fear of stocks all the way to offering clear and successful guidance on complicated-sounding options trades, we can help.

Feb 1, 2016 at 4:54PM

To be perfectly clear, this is not a get-rich action that my Foolish colleagues and I came up with. But we wouldn't argue with the approach.

A 2015 Business Insider article titled, "11 websites to bookmark if you want to get rich" rated The Motley Fool as the #1 place online to get smarter about investing.

"The Motley Fool aims to build a strong investment community, which it does by providing a variety of resources: the website, books, a newspaper column, a radio [show], and [newsletters]," wrote (the clearly insightful and talented) money reporter Kathleen Elkins. "This site has something for every type of investor, from basic lessons for beginners to investing commentary on mutual funds, stock sectors, and value for the more advanced."

Our mission at The Motley Fool is to help the world invest better, so it's nice to receive that kind of recognition. It lets us know we're doing our job.

Whether that's helping the entirely uninitiated overcome their fear of stocks all the way to offering clear and successful guidance on complicated-sounding options trades, we want to provide our readers with a boost to the next step on their journey to financial independence.

Articles and beyond

As Business Insider wrote, there are a number of resources available from the Fool for investors of all levels and styles.

In addition to the dozens of free articles we publish every day on our website, I want to highlight two must-see spots in your tour of fool.com.

For the beginning investor

Investing can seem like a Big Deal to those who have yet to buy their first stock. Many investment professionals try to infuse the conversation with jargon in order to deter individual investors from tackling it on their own (and to justify their often sky-high fees).

But the individual investor can beat the market. The real secret to investing is that it doesn't take tons of money, endless hours, or super-secret formulas that only experts possess.

That's why we created a best-selling guide that walks investors-to-be through everything they need to know to get started. And because we're so dedicated to our mission, we've made that available for free.

If you're just starting out (or want to help out someone who is), go to www.fool.com/beginners, drop in your email address, and you'll be able to instantly access the quick-read guide ... for free.

For the listener

Whether it's on the stationary exercise bike or during my daily commute, I spend a lot of time going nowhere. But I've found a way to make that time benefit me.

The Motley Fool offers five podcasts that I refer to as "binge-worthy financial information."

Motley Fool Money features a team of our analysts discussing the week's top business and investing stories, interviews, and an inside look at the stocks on our radar. It's also featured on several dozen radio stations across the country.

The hosts of Motley Fool Answers challenge the conventional wisdom on life's biggest financial issues to reveal what you really need to know to make smart money moves.

David Gardner, co-founder of The Motley Fool, is among the most respected and trusted sources on investing. And he's the host of Rule Breaker Investing, in which he shares his insights into today's most innovative and disruptive companies ... and how to profit from them.

Market Foolery is our daily look at stocks in the news, as well as the top business and investing stories.

And Industry Focus offers a deeper dive into a specific industry and the stories making headlines. Healthcare, technology, energy, consumer goods, and other industries take turns in the spotlight.

They're all informative, entertaining, and eminently listenable ... and I don't say that simply because the hosts all sit within a Nerf-gun shot of my desk. Rule Breaker Investing and Answers contain timeless advice, so you might want to go back to the beginning with those. The other three take their cues from the market, so you'll want to listen to the most recent first. All are available at www.fool.com/podcasts.

But wait, there's more

The book and the podcasts – both free ... both awesome – also come with an ongoing benefit. If you download the book, or if you enter your email address in the magical box at the podcasts page, you'll get ongoing market coverage sent straight to your inbox.

Investor Insights is valuable and enjoyable coverage of everything from macroeconomic events to investing strategies to our analyst's travels around the world to find the next big thing. Also free.

Get the book. Listen to a podcast. Sign up for Investor Insights. I'm not saying that any of those things will make you rich ... but Business Insider seems to think so.


Compare Brokers